December 27, 2017 / 1:09 PM / 6 months ago

BRIEF-Diffusion Pharmaceuticals Begins Phase 3 Clinical Trial With TSC In Glioblastoma Multiforme

Dec 27 (Reuters) - Diffusion Pharmaceuticals Inc:

* DIFFUSION PHARMACEUTICALS BEGINS PHASE 3 CLINICAL TRIAL WITH TSC IN GLIOBLASTOMA MULTIFORME

* DIFFUSION PHARMA - PROJECTS ENROLLMENT WILL BE COMPLETED BY EARLY 2019, WITH INTERIM SAFETY, EFFICACY DATA POSSIBLE IN 2020, TRIAL COMPLETION IN 2021 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below